Cargando…
Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas
BACKGROUND: With the availability of effective anti-EGFR therapies for various solid malignancies, such as non-cell small lung cancer, colorectal cancer and squamous cell carcinoma of the head and neck, the knowledge of EGFR and K-RAS status becomes clinically important. The aim of this study was to...
Autores principales: | Van Damme, Nancy, Deron, Philippe, Van Roy, Nadine, Demetter, Pieter, Bols, Alain, Dorpe, Jo Van, Baert, Filip, Van Laethem, Jean-Luc, Speleman, Franki, Pauwels, Patrick, Peeters, Marc |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887399/ https://www.ncbi.nlm.nih.gov/pubmed/20459770 http://dx.doi.org/10.1186/1471-2407-10-189 |
Ejemplares similares
-
Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
por: Arsenijevic, Tatjana, et al.
Publicado: (2021) -
Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014) -
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
por: De Pauw, Ines, et al.
Publicado: (2019) -
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
por: Maréchal, Raphaël, et al.
Publicado: (2010) -
Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?
por: Demetter, Pieter, et al.
Publicado: (2021)